Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer
Go back to Tempus Expands AI-Enabled Care Pathway Intelligence Platform into Breast Cancer| StemCells, Inc. (NASDAQ: TEM) | Delayed: 85.59 +0.58 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.01 | 52 Week High | $0.45 | |||
| Open | $83.57 | 52 Week Low | $0.37 | |||
| Day High | $86.29 | P/E | N/A | |||
| Day Low | $82.77 | EPS | $-0.31 | |||
| Volume | 3,410,369 | |||||
